Benzimidazoles derivatives with (2-{6-Chloro-5-nitro-1-[2-(1H-tetrazol-5-yl) biphenyl- 4-ylmethyl] 1H-benzoimidazol-2-yl}-phenyl)-(substituted-benzylidene)-amine with potential angiotensin II receptor antagonists as antihypertensive activity
Keywords:
Benzimidazole, Antihypertensive, 4-chloro-o-Phenylenediamine, Biphenyl tetrazole, Blood pressureAbstract
In this study we have synthesized some Benzimidazole derivatives (2-{6- Chloro-5-nitro-1-[2-(1H-tetrazol-5-yl) biphenyl-4-ylmethyl] 1Hbenzoimidazol-2-yl}-phenyl)-(Substituted-benzylidene)-amine and screened for their antihypertensive activity. 4-chloro-o-Phenylenediamine was condensed with anthranilic acid in presence of Polyphosphoric acid and different aryl aldehydes compounds with biphenyl tetrazole ring. The presence of specific functional group were analysed by IR spectroscopy, The determination of structure for the synthesized compounds by NMR and Mass spectroscopy 13C NMR, 1H NMR, FAB Mass. All the synthesized compounds showed significant antihypertensive activity.
References
Haugwitz RD, Antiparasitic agents Synthesis and
antihelmintic activities of novel 2- substituted
isothiocyanatobenzoxazoles and benzimidazole. J
Med Chem1982; 25: 969-974.
Hisano T, Synthesis of benzoxazloes,
benzothiazoles and benzimidazoles and evaluation
of their antifungal, insecticidal and herbicidal
activities. Chem PharmBull 1982; 30: 2996-3004.
Hubschwerlen C, Pyrimido [1, 6-a]
benzimidazoles: New class of DNA gyrase
inhibitors. J MedChem1992; 35: 1385.
Kim J.S, Structure activity relationships of
benzimidazoles and related heterocylces as
topoisomerase I poison. Borg Med Chem. 1996;
: 621-630.
Shi D.F, Synthesis of 2-(4-aminophenyl)
benzothiazoles and evaluation of their activities
against breast cancer cell lines in vitro and in
vivo. J Med Chem1996; 39: 3375-3384.
Gilman G, Goodman SL, Rall TW, Murad F.In:
The Pharmacological Basis of Therapeutics.7th
ed.New York: Macmillan Publishing Co, 1985:
–659.
Smith RD, Chiu AT, Wong PC, Herblin WF,
Timmermans PBMWM. Pharmacology of
Nonpeptide Angiotensin II Receptor
Antagonist.Ann RevPharmacol Toxicol. 1992; 32:
–165.
Berecek K. H, King, S. J, WuJ. N, AngiotensinConverting Enzyme and Converting Enzyme
Inhibitors. Cellular and Molecular Biology of the
Renin-Angiotensin System; CRC Press: Boca
Raton, FL, 1994; 183-220
KleinertH. D, Recent Developments in Renin
Inhibitors. Exp. Opin. Invest. Drugs, 1994; 3:
-1104.
Dutta A.S, Design and Therapeutic Potential of
Peptides. In Advances in Drug Research; Testa,
B., Ed.Academic Press: London, 1991; 21: 147-
Bali A, Bansal Y, Sugumaran M, Saggu J.S,
Balakumar P, Kaur G, Bansal G, Sharma A, Singh
M. Design, synthesis and evaluation of novelly
substituted benzimidazole compounds as
angiotensin II receptor antagonists. Bio Med
Chem Lett 2005;15: 3962-3965.
Dhvanit I. S, Sharma M, Bansal Y,Bansal G, M.
Singh. Angiotensin II AT1 receptor antagonists:
Design, synthesis and evaluation of substituted
carboxamido benzimidazole derivatives European
Journal of Medicinal Chemistry 2008; 43: 1808-
Jat R.K, Jat J.L, Pathak D.P.Synthesis of
Benzimidazole Derivatives: As Anti-hypertensive
Agents.E Journal of Chemistry 2006;3: 278-285.
Badyal D.K, Lata H, Dadhich A.P, Animal
models of hypertension and effect of drugs. Indian
J of Pharmacology 2003; 35: 349-362.
Bunag R.D, McCubbin J.W, Page I.H. Lack of
correlation between direct and indirect
measurements of arterial pressure in unanaesthetized rats. Cardiovasc Res 1971;5:24-31.
Gupta S.K.Drug Screening methods, Jaypee
Brothers Medical Publisher, New Delhi,2004; pp
-246.
